Lv1
70 积分 2022-03-27 加入
Effect of adjuvant EGFR-TKI therapy on the prognosis of pathological stage I invasive lung adenocarcinoma with sensitive EGFR mutations
2天前
已完结
Current management of uncommon EGFR mutations in non-small cell lung cancer
15天前
已完结
PT1.07.02 Neoadjuvant Ensartinib for ALK-Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC): A Multicenter, Real-World Study
1个月前
已关闭
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
2个月前
已完结
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2个月前
已完结
Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses
4个月前
已完结
Cancer mRNA vaccines: clinical advances and future opportunities
4个月前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
5个月前
已完结
Treatment of NSCLC after chemoimmunotherapy - are we making headway?
5个月前
已完结
The next generation of immunotherapies for lung cancers
5个月前
已完结
皖公网安备34019202002308
